Sera Prognostics, Inc. (SERA)
2.16
-0.14
(-6.09%)
USD |
NASDAQ |
Apr 07, 16:00
2.195
+0.04
(+1.62%)
After-Hours: 20:00
Sera Prognostics EPS Diluted (Quarterly) : -0.1577 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Co-Diagnostics, Inc. | -12.29 |
| Celldex Therapeutics, Inc. | -1.223 |
| Plus Therapeutics, Inc. | -1.03 |
| Atossa Therapeutics, Inc. | -1.270 |
| Abeona Therapeutics, Inc. | -0.3717 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -7.881M |
| Revenue (Quarterly) | 0.01M |
| Total Expenses (Quarterly) | 7.891M |
| Enterprise Value | 47.69M |
| Gross Profit Margin (Quarterly) | -2.47K% |
| Profit Margin (Quarterly) | -78.81K% |
| Earnings Yield | -32.73% |
| Normalized Earnings Yield | -32.72 |